174 related articles for article (PubMed ID: 9042207)
1. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia.
Berggren M; Gallegos A; Gasdaska JR; Gasdaska PY; Warneke J; Powis G
Anticancer Res; 1996; 16(6B):3459-66. PubMed ID: 9042207
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.
Gallegos A; Berggren M; Gasdaska JR; Powis G
Cancer Res; 1997 Nov; 57(21):4965-70. PubMed ID: 9354464
[TBL] [Abstract][Full Text] [Related]
3. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells.
Gallegos A; Gasdaska JR; Taylor CW; Paine-Murrieta GD; Goodman D; Gasdaska PY; Berggren M; Briehl MM; Powis G
Cancer Res; 1996 Dec; 56(24):5765-70. PubMed ID: 8971189
[TBL] [Abstract][Full Text] [Related]
4. The thioredoxin/thioredoxin reductase redox system and control of cell growth.
Powis G; Oblong JE; Gasdaska PY; Berggren M; Hill SR; Kirkpatrick DL
Oncol Res; 1994; 6(10-11):539-44. PubMed ID: 7620223
[TBL] [Abstract][Full Text] [Related]
5. Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism.
Gasdaska JR; Berggren M; Powis G
Cell Growth Differ; 1995 Dec; 6(12):1643-50. PubMed ID: 9019170
[TBL] [Abstract][Full Text] [Related]
6. The thioredoxin-thioredoxin reductase system: over-expression in human cancer.
Lincoln DT; Ali Emadi EM; Tonissen KF; Clarke FM
Anticancer Res; 2003; 23(3B):2425-33. PubMed ID: 12894524
[TBL] [Abstract][Full Text] [Related]
7. Selenium and the thioredoxin redox system: effects on cell growth and death.
Powis G; Gasdaska JR; Gasdaska PY; Berggren M; Kirkpatrick DL; Engman L; Cotgreave IA; Angulo M; Baker A
Oncol Res; 1997; 9(6-7):303-12. PubMed ID: 9406236
[TBL] [Abstract][Full Text] [Related]
8. Cellular thioredoxin reductase activity is regulated by selenium.
Berggren M; Gallegos A; Gasdaska J; Powis G
Anticancer Res; 1997; 17(5A):3377-80. PubMed ID: 9413175
[TBL] [Abstract][Full Text] [Related]
9. Quantification of alternative mRNA species and identification of thioredoxin reductase 1 isoforms in human tumor cells.
Rundlöf AK; Fernandes AP; Selenius M; Babic M; Shariatgorji M; Nilsonne G; Ilag LL; Dobra K; Björnstedt M
Differentiation; 2007 Feb; 75(2):123-32. PubMed ID: 17316382
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin reductase may be essential for the normal growth of hyperbaric oxygen-treated human lens epithelial cells.
Padgaonkar VA; Leverenz VR; Dang L; Chen SC; Pelliccia S; Giblin FJ
Exp Eye Res; 2004 Dec; 79(6):847-57. PubMed ID: 15642322
[TBL] [Abstract][Full Text] [Related]
11. Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination.
Hu J; Ma X; Lindner DJ; Karra S; Hofmann ER; Reddy SP; Kalvakolanu DV
Oncogene; 2001 Jul; 20(31):4235-48. PubMed ID: 11464290
[TBL] [Abstract][Full Text] [Related]
12. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-dependent suppression of thioredoxin-interacting protein expression enhances thioredoxin activity.
Schulze PC; Liu H; Choe E; Yoshioka J; Shalev A; Bloch KD; Lee RT
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2666-72. PubMed ID: 17023680
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.
Yamada M; Tomida A; Yoshikawa H; Taketani Y; Tsuruo T
Clin Cancer Res; 1996 Feb; 2(2):427-32. PubMed ID: 9816187
[TBL] [Abstract][Full Text] [Related]
16. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.
Soini Y; Kahlos K; Näpänkangas U; Kaarteenaho-Wiik R; Säily M; Koistinen P; Pääakkö P; Holmgren A; Kinnula VL
Clin Cancer Res; 2001 Jun; 7(6):1750-7. PubMed ID: 11410516
[TBL] [Abstract][Full Text] [Related]
17. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy.
Husain I; Mohler JL; Seigler HF; Besterman JM
Cancer Res; 1994 Jan; 54(2):539-46. PubMed ID: 8275492
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival.
Raffel J; Bhattacharyya AK; Gallegos A; Cui H; Einspahr JG; Alberts DS; Powis G
J Lab Clin Med; 2003 Jul; 142(1):46-51. PubMed ID: 12878985
[TBL] [Abstract][Full Text] [Related]
19. Treatment of lung cancer cells with cytotoxic levels of sodium selenite: effects on the thioredoxin system.
Selenius M; Fernandes AP; Brodin O; Björnstedt M; Rundlöf AK
Biochem Pharmacol; 2008 Jun; 75(11):2092-9. PubMed ID: 18405881
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo.
Baker A; Payne CM; Briehl MM; Powis G
Cancer Res; 1997 Nov; 57(22):5162-7. PubMed ID: 9371519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
